Literature DB >> 2193476

Predictive value of quantitative cisternography in normal pressure hydrocephalus.

A Larsson1, M Moonen, A C Bergh, S Lindberg, C Wikkelsö.   

Abstract

Twenty-five patients with normal pressure hydrocephalus (NPH) and 16 patients with cerebral atrophy were investigated by quantitative cisternography using anterior images of the head 3, 6 and 24 h after a lumbar injection of 200 MBq 99mTc DTPA (diethylene-triamine-penta-acetic acid). The activity in the lateral ventricles, basal cisterns, hemispheric convexities and total intracranial region was measured. Ratios between these regions/quantities were calculated. Fifteen of the NPH patients improved while 10 were unchanged after ventriculo-peritoneal shunt surgery. The ratio between ventricular and total intracranial activity (V/T) correlated positively with the degree of improvement after shunt surgery. All NPH patients with a V/T ratio higher than 32% improved after the operation but a V/T ratio less than 32% did not exclude the possibility of improvement. With regard to quantitative measurements, the radionuclide cisternography procedure can be reduced to imaging at 24 h.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193476     DOI: 10.1111/j.1600-0404.1990.tb01564.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

1.  Does the shunt opening pressure influence the effect of shunt surgery in normal pressure hydrocephalus?

Authors:  A Larsson; C Jensen; M Bilting; S Ekholm; H Stephensen; C Wikkelsö
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

2.  Correlation of midbrain diameter and gait disturbance in patients with idiopathic normal pressure hydrocephalus.

Authors:  Phil Hyu Lee; Suk Woo Yong; Young Hwan Ahn; Kyoon Huh
Journal:  J Neurol       Date:  2005-04-19       Impact factor: 4.849

3.  Cxcl10+ monocytes define a pathogenic subset in the central nervous system during autoimmune neuroinflammation.

Authors:  Amir Giladi; Lisa Katharina Wagner; Hanjie Li; Dorothea Dörr; Chiara Medaglia; Franziska Paul; Anat Shemer; Steffen Jung; Simon Yona; Matthias Mack; Achim Leutz; Ido Amit; Alexander Mildner
Journal:  Nat Immunol       Date:  2020-04-20       Impact factor: 25.606

4.  CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy.

Authors:  M Tullberg; J E Månsson; P Fredman; A Lekman; K Blennow; R Ekman; L E Rosengren; M Tisell; C Wikkelsø
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

Review 5.  Brain MRI as a predictor of CSF tap test response in patients with idiopathic normal pressure hydrocephalus.

Authors:  Wei-Ju Lee; Shuu-Jiun Wang; Li-Chi Hsu; Jiing-Feng Lirng; Chen-Hao Wu; Jong-Ling Fuh
Journal:  J Neurol       Date:  2010-05-29       Impact factor: 4.849

Review 6.  Transmantle and transvenous pressure gradients in cerebrospinal fluid disorders.

Authors:  Mendel Castle-Kirszbaum; Tony Goldschlager
Journal:  Neurosurg Rev       Date:  2021-08-14       Impact factor: 3.042

7.  Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects.

Authors:  A Larsson; A C Bergh; M Bilting; A Arlig; L Jacobsson; H Stephensen; C Wikkelsö
Journal:  Eur J Nucl Med       Date:  1994-02

Review 8.  MR assessment of pediatric hydrocephalus: a road map.

Authors:  Charles Raybaud
Journal:  Childs Nerv Syst       Date:  2015-09-04       Impact factor: 1.475

9.  Movement disorders at a university hospital emergency room. An analysis of clinical pattern and etiology.

Authors:  Jung Han Yoon; Phil Hyu Lee; Seok Woo Yong; Hee Young Park; Tae Sung Lim; Jun Young Choi
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

Review 10.  Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

Authors:  João Casaca-Carreira; Yasin Temel; Sarah-Anna Hescham; Ali Jahanshahi
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.